Intuitive Surgical (NASDAQ:ISRG) EVP Gary Loeb Sells 400 Shares

Intuitive Surgical, Inc. (NASDAQ:ISRG) EVP Gary Loeb sold 400 shares of the business’s stock in a transaction that occurred on Wednesday, June 10th. The stock was sold at an average price of $424.14, for a total transaction of $169,656.00. Following the completion of the transaction, the executive vice president owned 5,720 shares in the company, valued at $2,426,080.80. This trade represents a 6.54% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Gary Loeb also recently made the following trade(s):

• On Monday, May 11th, Gary Loeb sold 400 shares of Intuitive Surgical stock. The stock was sold at an average price of $446.95, for a total transaction of $178,780.00.

Intuitive Surgical Stock Performance

Shares of NASDAQ ISRG opened at $412.02 on Thursday. The company has a market capitalization of $145.92 billion, a P/E ratio of 49.94, a price-to-earnings-growth ratio of 3.41 and a beta of 1.46. Intuitive Surgical, Inc. has a 52-week low of $396.68 and a 52-week high of $603.88. The company’s 50 day moving average price is $444.91 and its 200-day moving average price is $497.84.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.08 by $0.42. Intuitive Surgical had a net margin of 28.15% and a return on equity of 15.98%. The firm had revenue of $2.77 billion for the quarter, compared to the consensus estimate of $2.62 billion. During the same quarter in the previous year, the company earned $1.81 EPS. The company’s revenue for the quarter was up 23.0% on a year-over-year basis. Analysts forecast that Intuitive Surgical, Inc. will post 8.57 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of research analysts recently issued reports on the stock. Robert W. Baird boosted their target price on shares of Intuitive Surgical from $575.00 to $610.00 and gave the company an “outperform” rating in a research report on Wednesday, April 22nd. Jefferies Financial Group decreased their price target on shares of Intuitive Surgical from $560.00 to $515.00 and set a “hold” rating for the company in a research note on Wednesday, April 22nd. Mizuho set a $525.00 price target on shares of Intuitive Surgical and gave the company a “neutral” rating in a research note on Monday, April 13th. BTIG Research reiterated a “buy” rating and issued a $574.00 target price on shares of Intuitive Surgical in a research note on Wednesday, April 22nd. Finally, Piper Sandler reiterated an “overweight” rating and issued a $580.00 target price on shares of Intuitive Surgical in a research note on Tuesday, June 2nd. Nineteen research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $573.63.

Key Stories Impacting Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: ISRG was upgraded to a Zacks Rank #2 (Buy), signaling improving earnings expectations and adding a bullish catalyst for the stock.
• Positive Sentiment: Analysts say Intuitive Surgical can use its scale, cost discipline, and growing da Vinci 5 adoption to offset tariff and input-cost pressure, which supports the company’s margin outlook.
• Positive Sentiment: The stock also recently outperformed the broader market, reflecting continued investor confidence in its growth profile. Article: Intuitive Surgical, Inc. (ISRG) Rises As Market Takes a Dip: Key Facts
• Neutral Sentiment: Two executives sold shares under pre-arranged Rule 10b5-1 plans, including EVP Gary Loeb and EVP Mark Brosius. The sales were relatively small and routine, so they may be viewed more as portfolio management than a major red flag.
• Neutral Sentiment: Analyst commentary also noted that ISRG’s fair value estimate was reset lower, which suggests some caution remains despite the company’s long-term growth story.

Hedge Funds Weigh In On Intuitive Surgical

Several institutional investors have recently added to or reduced their stakes in ISRG. Norges Bank bought a new position in Intuitive Surgical during the fourth quarter valued at about $2,856,987,000. J. Stern & Co. LLP grew its position in Intuitive Surgical by 18,504.6% during the fourth quarter. J. Stern & Co. LLP now owns 2,127,248 shares of the medical equipment provider’s stock valued at $1,204,788,000 after buying an additional 2,115,814 shares during the period. Northwestern Mutual Wealth Management Co. grew its position in Intuitive Surgical by 1,043.3% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 1,342,121 shares of the medical equipment provider’s stock valued at $760,124,000 after buying an additional 1,224,734 shares during the period. Arrowstreet Capital Limited Partnership grew its position in Intuitive Surgical by 95.3% during the first quarter. Arrowstreet Capital Limited Partnership now owns 2,105,544 shares of the medical equipment provider’s stock valued at $970,635,000 after buying an additional 1,027,475 shares during the period. Finally, Polen Capital Management LLC bought a new position in Intuitive Surgical during the fourth quarter valued at about $477,225,000. Institutional investors own 83.64% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.